Guideline Update: PrEP to Prevent HIV and Promote Sexual Health
What's New: This update incorporates data published since the 2020 edition and adds recommendations for use of long-acting injectable cabotegravir as pre-exposure prophylaxis (PrEP).
If this newsletter was forwarded to you, please subscribe now to make sure you receive the Clinical Guidelines Program news every month and stay current with new and updated guidelines.
Subscribing is as easy as entering your email address. We will send you just 1 email per month, and we do not share our mailing list.
Comment? Question? Suggestion?Drop us a line: aiguidelines@mail219.jh.eduWe welcome feedback and suggestions, and if you send us a question, we will get back to you as quickly as possible. Please note, however, that we cannot answer questions about the care or treatment of specific patients and cannot provide clinical advice.
New York State Department of Health AIDS Institute In collaboration with the Division of Infectious Diseases | Johns Hopkins University School of Medicine